LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 1 | 48.65 | 84.90 | 1415 | 5328 | 0.2655 | 0.6018 | MN20160318_Q02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 48.65 | 84.90 | 1430 | 5328 | 0.2684 | 0.6046 | MN20160318_Q02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 50.36 | 84.90 | 1444 | 5651 | 0.2555 | 0.5966 | MN20160318_Q02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 50.36 | 84.90 | 1467 | 5651 | 0.2596 | 0.6008 | MN20160318_Q02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 50.36 | 84.90 | 1348 | 5651 | 0.2385 | 0.5786 | MN20160318_Q02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 50.36 | 84.90 | 1376 | 5651 | 0.2435 | 0.5839 | MN20160318_Q02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 52.06 | 84.90 | 1400 | 5990 | 0.2337 | 0.5784 | MN20160318_Q02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 52.06 | 84.90 | 1418 | 5990 | 0.2367 | 0.5817 | MN20160318_Q02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 52.06 | 84.90 | 1381 | 5990 | 0.2305 | 0.5749 | MN20160318_Q02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 52.06 | 84.90 | 1403 | 5990 | 0.2342 | 0.5790 | MN20160318_Q02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 53.77 | 84.90 | 1400 | 6252 | 0.2239 | 0.5713 | MN20160318_Q02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 53.77 | 84.90 | 1417 | 6252 | 0.2266 | 0.5743 | MN20160318_Q02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 53.77 | 84.90 | 1333 | 6252 | 0.2132 | 0.5589 | MN20160318_Q02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 53.77 | 84.90 | 1352 | 6252 | 0.2162 | 0.5624 | MN20160318_Q02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 55.48 | 84.90 | 1435 | 6567 | 0.2185 | 0.5694 | MN20160318_Q02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 55.48 | 84.90 | 1451 | 6567 | 0.2209 | 0.5722 | MN20160318_Q02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 55.48 | 84.90 | 1395 | 6567 | 0.2124 | 0.5624 | MN20160318_Q02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 55.48 | 84.90 | 1413 | 6567 | 0.2151 | 0.5656 | MN20160318_Q02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 57.18 | 84.90 | 1396 | 6963 | 0.2005 | 0.5533 | MN20160318_Q02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 57.18 | 84.90 | 1412 | 6963 | 0.2028 | 0.5561 | MN20160318_Q02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 57.18 | 84.90 | 1389 | 6963 | 0.1995 | 0.5521 | MN20160318_Q02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 57.18 | 84.90 | 1405 | 6963 | 0.2018 | 0.5549 | MN20160318_Q02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 58.88 | 84.90 | 1423 | 7291 | 0.1952 | 0.5509 | MN20160318_Q02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 58.88 | 84.90 | 1440 | 7291 | 0.1975 | 0.5537 | MN20160318_Q02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 58.88 | 84.90 | 1407 | 7291 | 0.1930 | 0.5481 | MN20160318_Q02 | I10 |